In order to clarify the structural changes that occur in the thermochromic phase transition of poly (3‐dodecylthiophene) [P3DT] and poly (3‐hexylthiophene) [P3HT], the temperature dependence of x‐ray diffraction and Fourier transform infrared spectra was measured. (1) Orthogonal unit‐cell parameters were determined at room temperature: a=25.83 Å, b=7.75 Å, c (fiber axis)=7.77 Å for P3DT and a=16.63 Å, b=7.75 Å, and c=7.77 Å for P3HT. A large variation of the a‐axis length between P3DT and P3HT indicates the extended trans conformation for the alkyl side chains which are oriented along the lateral a‐axis direction. (2) The interplanar spacing, intensity, and integral width of the x‐ray (h00) and (00l) reflections were found to change drastically in the transition region. (3) Polarized infrared measurements at high temperature revealed a marked increase of the gauche band intensity for the alkyl side group modes followed by a decrease in the band intensity of the thiophene ring modes. (4) The layer reflections of the x‐ray fiber diagram become diffuse at high temperatures, indicating that the transition occurs in a liquidcrystalline manner with the orientation of the main chain axes preserved but with almost no axial correlation between the neighboring main chains. These results provide experimental support for the structural model proposed earlier: as the temperature increases, the trans‐type side chains begin to disorder by introduction of gauche bonds. This disordering disrupts the regularity of the main chain conformation and decreases the effective length of the polythiophene conjugated system.

Background/Aims: Chinese herbal medicine Qing-Dai (also known as indigo naturalis) has been used to treat various inflammatory conditions. However, not much has been studied about the use of oral Qing-Dai in the treatment for ulcerative colitis (UC) patients. Studies exploring alternative treatments for UC are of considerable interest. In this study, we aimed at prospectively evaluating the safety and efficacy of Qing-Dai for UC patients. Methods: The open-label, prospective pilot study was conducted at Keio University Hospital. A total of 20 patients with moderate UC activity were enrolled. Oral Qing-Dai in capsule form was taken twice a day (daily dose, 2 g) for 8 weeks. Results: At week 8, the rates of clinical response, clinical remission, and mucosal healing were 72, 33, and 61%, respectively. The clinical and endoscopic scores, CRP levels, and fecal occult blood results were also significantly improved. We observed 2 patients with mild liver dysfunction; 1 patient discontinued due to infectious colitis and 1 patient discontinued due to mild nausea. Conclusion: This is the first prospective study indicating that oral Qing-Dai is effective for inducing remission in patients with moderate UC activity and can be tolerated. Thus, Qing-Dai may be considered an alternative treatment for patients, although further investigation is warranted.

Calcineurin inhibition, if started from the initial stage of pressure overload, attenuated the development of LV hypertrophy without any effect on LV fibrosis and prevented the transition to heart failure. The activation of calcineurin is involved in the development of LV hypertrophy but not of LV fibrosis, and this involvement may be crucial at the initial stage.

Development of pressure overload LV hypertrophy is associated with evolving changes in MFVP from normal to relaxation abnormality pattern and, in turn, to pseudonormalized to restrictive pattern. Analysis of MFVP may be useful to follow not only functional but also constitutional changes of the myocardium in hypertensive hearts.